|

Indocyanine Green Solution Clinical Trials

1 actively recruiting trial across 1 location

Also known as: IC-GREEN, ICG Solution

Pipeline

Phase 3: 1

Top Sponsors

  • NRG Oncology1

Indications

  • Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v81
  • Cancer1

Washington D.C., District of Columbia1 trial

Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

George Washington University Medical Center

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.